374 related articles for article (PubMed ID: 28477537)
1. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
[TBL] [Abstract][Full Text] [Related]
3. Platinum(II) Complexes with Bulky Disubstitute Triazolopyrimidines as Promising Materials for Anticancer Agents.
Łakomska I; Śmiłowicz D; Jakubowski M; Sitkowski J; Wojtczak A
Materials (Basel); 2020 Nov; 13(23):. PubMed ID: 33255252
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
5. Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine.
Łakomska I; Fandzloch M; Muzioł T; Sitkowski J; Wietrzyk J
J Inorg Biochem; 2012 Oct; 115():100-5. PubMed ID: 22926029
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
[TBL] [Abstract][Full Text] [Related]
7. First dinuclear rhodium(II) complexes with triazolopyrimidines and the prospect of their potential biological use.
Fandzloch M; Augustyniak AW; Dobrzańska L; Jędrzejewski T; Sitkowski J; Wypij M; Golińska P
J Inorg Biochem; 2020 Sep; 210():111072. PubMed ID: 32563102
[TBL] [Abstract][Full Text] [Related]
8. Factors Affecting the Stability of Platinum(II) Complexes with 1,2,4-Triazolo[1,5-
Jakubowski M; Łakomska I; Kaszuba A; Wojtczak A; Sitkowski J; Jarzęcki AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409016
[TBL] [Abstract][Full Text] [Related]
9. Multinuclear NMR spectroscopy and antitumor activity of novel platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines.
Łakomska I; Szłyk E; Sitkowski J; Kozerski L; Wietrzyk J; Pełczyńska M; Nasulewicz A; Opolski A
J Inorg Biochem; 2004 Jan; 98(1):167-72. PubMed ID: 14659646
[TBL] [Abstract][Full Text] [Related]
10. Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines.
Fandzloch M; Jaromin A; Zaremba-Czogalla M; Wojtczak A; Lewińska A; Sitkowski J; Wiśniewska J; Łakomska I; Gubernator J
Dalton Trans; 2020 Jan; 49(4):1207-1219. PubMed ID: 31903475
[TBL] [Abstract][Full Text] [Related]
11. Mono- and dinuclear platinum(II) compounds with 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine. Structure, cytotoxic activity and reaction with 5'-GMP.
Łakomska I; Kooijman H; Spek AL; Shen WZ; Reedijk J
Dalton Trans; 2009 Dec; (48):10736-41. PubMed ID: 20023903
[TBL] [Abstract][Full Text] [Related]
12. Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine].
Trávnícek Z; Malon M; Zatloukal M; Dolezal K; Strnad M; Marek J
J Inorg Biochem; 2003 Apr; 94(4):307-16. PubMed ID: 12667701
[TBL] [Abstract][Full Text] [Related]
13. Novel cis-[(NHC)
Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R
Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959
[TBL] [Abstract][Full Text] [Related]
14. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
[TBL] [Abstract][Full Text] [Related]
15. New platinum (II) and palladium (II) complexes of coumarin-thiazole Schiff base with a fluorescent chemosensor properties: Synthesis, spectroscopic characterization, X-ray structure determination, in vitro anticancer activity on various human carcinoma cell lines and computational studies.
Şahin Ö; Özdemir ÜÖ; Seferoğlu N; Genc ZK; Kaya K; Aydıner B; Tekin S; Seferoğlu Z
J Photochem Photobiol B; 2018 Jan; 178():428-439. PubMed ID: 29216566
[TBL] [Abstract][Full Text] [Related]
16. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
[TBL] [Abstract][Full Text] [Related]
17. Platinum(II) Complexes with 1,10-Phenanthroline and Hydrophilic Alkoxyacetate Ligands as Potential Antitumor Agents.
Sun Y; Wei H; Zhang Q; Zhao X
Chem Biodivers; 2019 Jan; 16(1):e1800373. PubMed ID: 30414350
[TBL] [Abstract][Full Text] [Related]
18. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
Margiotta N; Savino S; Gandin V; Marzano C; Natile G
ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
[TBL] [Abstract][Full Text] [Related]
19. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
20. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
Ma L; Ma R; Wang Z; Yiu SM; Zhu G
Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
